Lambda Pharmaceuticals

Las Vegas, NV 89134

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $200K
First Award Date 08/10/97
Most Recent Award Date 09/01/01

Key Personnel

Last Name Name Awards Contact
Morgan Alan R Morgan 3
Hall Robert C Hall 1

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/01 - 06/30/02

DESCRIPTION (From the Applicant's Abstract): Photodynamic therapy (PDT) is a new potential treatment of the subfoveal choroidal neovascularization (CNV) that may accompany age-related macular degeneration (AMD). PDT involves the use of a photosensitizing agent which, when ac...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/00 - 09/29/01

DESCRIPTION (Adapted from the Investigator's Abstract): Cholecystectomy results in bile duct damage in 3000 patients annually. To avoid these devastating injuries, the investigators propose an endoluminal operation using three technical innovations: 1) a cannula that attaches to the gallbladder surface, 2) a ra...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/98 - 07/31/99

DESCRIPTION: The applicants propose a novel and innovative method for the generation of activated oxygen species in biological systems, which may have utility in the field of photodynamic therapy. Specifically, they plan the development of redox-inert iron(III) chelate complexes that maintain coordinative s...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/10/97 - 05/09/98

Photodynamic therapy has been approved for certain indications in the USA, Japan, Canada, France and Netherlands. The only drug approved, Photofrin, is not ideal and a significant research effort has led to the development of second generation sensitizers. Many of these agents are hydrophobic and need fo...